Days
Hours
Minutes
Seconds

March 1 & 2, 2024

About

Desert Liver Retreat

We provide a superior scientific program and a fun opportunity to network with colleagues seeking an update in state-of-the-art liver disease care. Our exhibitors are chosen as excellent providers of important products and services to our community.

Target Audience

This event is intended for MDs, DOs, PAs, NPs, RNs, residents, fellows, and clinical research personnel who are involved in the care of patients with liver disease.

Educational Objectives

After attending this event the participant should be better able to:

  • Utilize most recent guidelines for screening and diagnosing patients at risk of chronic liver disease

  • Develop an evidence-based treatment regimen for chronic liver disease using latest clinical evidence

  • Communicate disease and treatment options to patients

  • Recognize and communicate risks and benefits of therapy

  • Recognize differential diagnosis for NAFLD & NASH

  • Characterize risk factors for PBC & be able to discuss different therapies for PBC

  • Identify diagnostic approaches for HCC and treatment options

  • Explain diagnostic criteria and diagnostic tools for minimal and overt HE

  • Define diagnostic and therapeutic strategies for HCC

  • Demonstrate understanding of the diagnostic approaches for PSC and the role of liver biopsy as well as what therapies are used for PSC and when

  • Demonstrate understanding of different currently available treatment options for different clinical manifestations of portal hypertension

  • Choose different interventions and treatment approaches to minimize inpatient health care utilization for patients with liver disease

  • Describe the hepatic manifestations of COVID-19 infections including acute hepatic injury and cholangitis

2023 - Jointly provided by Pinnacle Clinical Research, PLLC.

Educational grant support is pending and any confirmed support received will be disclosed in future course materials.

Accreditation Statements

Coming Soon 

Physician Assistant Continuing Medical Education

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 7 CME credits for activities planned in accordance with AAPA CME Criteria.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 7.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses to be determined.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosures

Coming Soon 

2024 Agenda

Friday, March 1 - Steatotic Liver Disease Summit/ Noninvasive Tests (NITs) Workshop

1:00 AM - 1:05 PM

Opening Remarks

Stephen Harrison, MD, FACP, FAASLD

1:05 PM - 1:30 PM

Imaging NITs

Mazen Noureddin, MD, MHSc

1:30 PM - 1:55 PM

Serologic NITs

Meena Bansal, MD

1:55 PM - 2:20 PM

Selecting Patients for Treatment and Monitoring Response

Naim Alkhouri, MD, FAASLD or Stephen Harrison, MD, FACP, FAASLD

2:20 PM - 2:50 PM

Interactive Cases

Stephen Harrison, MD, FACP, FAASLD & Naim Alkhouri, MD, FAASLD

2:50 PM- 3:10 PM

Break

3:10 PM - 4:30 PM

NITs Demonstration (Echosens/ e-Scopics/ Sonic Incytes/ Siemens/ OWL)

Naim Alkhouri, MD, FAASLD, Meena Bansal, MD, Stephen Harrison, MD, FACP, FAASLD, Mazen Noureddin, MD, MHSc

4:30 PM - 5:15 PM

Panel Discussion on the Future of MASH Therapeutics

Naim Alkhouri, MD, FAASLD, Meena Bansal, MD, Stephen Harrison, MD, FACP, FAASLD, Mazen Noureddin, MD, MHSc

Saturday, March 2 - Agenda

7:00 AM - 8:30 AM

Registration & Exhibits

7:30 AM - 8:30 AM

Product Theater and Breakfast

8:30 AM - 8:35 AM

Opening Remarks

Naim Alkhouri, MD, FAASLD

SESSION ONE

(DILI/ Metabolic/ and Liver Transplant)


Moderator: Stephen Harrison, MD, FAASLD
Panelists: Richard Manch, MD, FAASLD, FACP, FACG, Naga Chalasani, Moises (IIan) Nevah Rubin, MD

8:35 AM - 9:00 AM

Drug Induced Liver Injury

Raj Vuppalanchi, MD

9:00 AM - 9:25 AM

The Big 3 of Genetic Liver Diseases: Hemochromatosis/ A1ATD/ Wilson Disease

Richard Manch, MD, FAASLD, FACP, FACG

9:25 AM - 9:50 AM

Liver Transplant for the Non-Specialist

Moises (IIan) Nevah Rubin, MD

9:50 AM - 10:15 AM

Panel Discussion

10:15 AM - 10:30 AM

Break & Exhibits in Foyer

SESSION TWO

MASLD and MASH

Moderator: Naim Alkhouri, MD, FAALSD
Panelists: Meena Bansal, MD,
Mazen Noureddin, MD, MHSc Stephen Harrison, MD, FACP, FAASLD, Naim Alkhouri, MD, FAALSD

10:30 AM - 10:50 AM

Steatotic Liver Desease (SLD) New Nomenclature: Implications and Implementation

Meena Bansal, MD

10:50 AM - 11:10 AM

All You Need to Know on Diagnosing MASLD: From Risk Stratification to Treatment Monitoring

Mazen Noureddin. MD

11:10 AM - 11:30 AM

Management of MASH with New Drugs: The Future Is Bright

Stephen Harrison, MD, FACP, FAASLD

11:30 AM - 12:00 PM

Practical SLD Cases and Panel Discussion

Naim Alkhouri, MD, FAASLD

12:15 PM - 12:30 PM

Panel Discussion

12:00 PM - 1:15 PM

Product Theater, Lunch, & Exhibits

SESSION THREE

Viral Hepatitis and Cholestasis

Moderator: Anita Kohli, MD
Panelists: Julio Gutierrez, MD, Raj Vuppalanchi, MD,
Naim Alkhouri, MD, FAASLD

1:15 PM - 1:35 PM

Treatment for HBV/HDV: Are we Close to a Cure?

Julio Gutierrez, MD

1:35 PM - 1:50 PM

HCV Elimination: Where are we?

Anita Kohli, MD

1:50 PM - 2:15 PM

PBC Update: New Drugs Coming Your Way Soon

Raj Vuppalanchi, MD

2:15 PM - 2:40 PM

Genetic Cholestasis for the Adult Provider

Kelly Dale, NP

2:40 PM - 3:00 PM

Panel Discussion

3:00 PM - 3:30 PM

Break & Exhibits in Foyer

SESSION FOUR

Cirrhosis

Moderator: Jacqueline O'Leary, MD Panelists: Elliot Tapper, MD, Jinendra Satiya, MD

3:30 PM - 3:55 PM

Cirrhosis/ Portal Hypertension Update: From HRS to HCC

Jacqueline O'Leary, MD, MPH

3:55 PM - 4:20 PM

Management of the Forgotton Symptoms of Cirrhosis: From Sarcopenia to Cramps and Beyond.

Elliot Tapper, MD

4:20 PM- 4:45 PM

Pulmonary Complications of Liver Disease

Jinendra Satiya, MD

4:45 PM - 5:00 PM

Panel Discussion

5:00 PM

Concluding Remarks

Reception to Follow for Registered Attendees and Sponsors

Course Directors

2023 Desert Liver Conference Faculty

Dr. Elliot Tapper

Dr. Elliot Tapper

    Dr. Meena Basal

    Dr. Meena Basal

      Dr. Moises (Ilan) Nevah Rubin

      Dr. Moises (Ilan) Nevah Rubin

        Dr. Raj Vuppalanchi

        Dr. Raj Vuppalanchi

          Kelly Dale, NP

          Kelly Dale, NP

            2024 Fees

            Registration Fees

            Early Bird Before 12/30

            Regular After 12/30

            In-person attendance (includes CME/MOC) ++ may be subject to facility and service fees

            $125++

            $150++

            In-person attendance, CEU, non-CME (nurses, fellows/students, and others not requesting CME credits, research personnel) ++ may be subject to facility and service fees

            $75++

            $100++

            Virtual attendance (includes CME and non-CME) ++ may be subject to facility and service fees

            $100++

            $125++

            Thank You 2024 Diamond Sponsors

            Thank You 2024 Top Sponsor

            Thank You 2024 Platinum Sponsors

            Thank You 2024 Gold Sponsor

            Thank You 2024 Silver Sponsors

            2024 Venue Information

            Arizona Biltmore

            2400 E. Missouri Ave., Phoenix, AZ 85016

            Phone: (602) 955-6600